Every SEC Form 3/4/5 on record for this filer (CIK 1681267) — 2 issuers, 63 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| DXCM | DEXCOM INC | EVP, Chief Financal Officer | 2020-03-10 → 2026-05-27 | 41 | −$9M |
| NUVA | NUVASIVE INC | Chief Accounting Officer · lapsed | 2016-08-03 → 2018-02-05 | 5 | — |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| DXCM | 2025-09-02 | Sell | 4,824 | $74.17 | $357,796 | 118,657 |
| DXCM | 2025-03-12 | Sell | 12,001 | $70.38 | $844,630 | 123,481 |
| DXCM | 2025-03-10 | Sell | 1,127 | $74.70 | $84,187 | 135,482 |
| DXCM | 2025-03-10 | Sell | 2,670 | $73.22 | $195,497 | 139,812 |
| DXCM | 2025-03-10 | Sell | 3,203 | $74.04 | $237,150 | 136,609 |
1 of 2 issuers are covered and open a security page; the rest are on file here only.